SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-024572
Filing Date
2019-07-05
Accepted
2019-07-05 08:33:02
Documents
3
Period of Report
2019-06-28
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acer-8k_20190628.htm 8-K 38081
2 EX-99.1 acer-ex991_48.htm EX-99.1 22476
3 GRAPHIC glyqle4zfvrk000001.jpg GRAPHIC 2729
  Complete submission text file 0001564590-19-024572.txt   65973
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 19943201
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1